TG Therapeutics Q1 2026 Earnings EPS Disappoints as Stock Declines COFS Q1 2026 Earnings EPS Beats Estimates by 55 Amid Mixed Market Reaction RM Q1 2026 Earnings EPS Surges Past Estimates as Regional Management Posts Strong Profit Beat SPMC Q1 2026 Earnings EPS Misses Estimates Despite Stock Rally ANRO Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Continues Investment in Pipeline CBRL Q1 2026 Earnings Significant EPS Beat Surprises Market